Does OSIMERTINIB Cause Neuropathy peripheral? 137 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 137 reports of Neuropathy peripheral have been filed in association with OSIMERTINIB (TAGRISSO). This represents 0.5% of all adverse event reports for OSIMERTINIB.
137
Reports of Neuropathy peripheral with OSIMERTINIB
0.5%
of all OSIMERTINIB reports
2
Deaths
12
Hospitalizations
How Dangerous Is Neuropathy peripheral From OSIMERTINIB?
Of the 137 reports, 2 (1.5%) resulted in death, 12 (8.8%) required hospitalization.
Is Neuropathy peripheral Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OSIMERTINIB. However, 137 reports have been filed with the FAERS database.
What Other Side Effects Does OSIMERTINIB Cause?
Death (10,423)
Malignant neoplasm progression (2,920)
Diarrhoea (1,408)
Drug resistance (1,026)
Fatigue (819)
Rash (772)
Decreased appetite (706)
Drug ineffective (627)
Dyspnoea (621)
Nausea (610)
What Other Drugs Cause Neuropathy peripheral?
LENALIDOMIDE (10,215)
BORTEZOMIB (4,067)
OXALIPLATIN (3,662)
DEXAMETHASONE (3,543)
PACLITAXEL (3,508)
LEVOFLOXACIN (2,619)
CIPROFLOXACIN (2,607)
FLUOROURACIL (2,605)
CYCLOPHOSPHAMIDE (2,565)
POMALIDOMIDE (2,382)
Which OSIMERTINIB Alternatives Have Lower Neuropathy peripheral Risk?
OSIMERTINIB vs OSPEMIFENE
OSIMERTINIB vs OSPHENA
OSIMERTINIB vs OVINE DIGOXIN IMMUNE FAB
OSIMERTINIB vs OXACILLIN
OSIMERTINIB vs OXALIPLATIN